Spinal anesthesia study aims to reduce dangerous blood pressure drops

NCT ID NCT07616882

First seen Jun 02, 2026 · Last updated Jun 22, 2026 · Updated 3 times

Summary

This phase 2 trial will test whether giving the anesthetic bupivacaine in two smaller doses (fractionated) instead of one large dose (bolus) leads to more stable blood pressure during spinal anesthesia for lower limb surgery. The study plans to enroll 100 adults aged 18-60 who are healthy or have mild systemic disease. Researchers will measure blood pressure changes and track any need for medication to treat low blood pressure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMONDYNAMIC CHANGES IN SPINAL ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Liaquat National Hospital

    Karachi, Sindh, 74000, Pakistan

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bupivacaine (spinal anesthetic)

What this could lead to

If successful, this could point toward a safer way to give spinal anesthesia that reduces sudden drops in blood pressure during surgery.

What could go wrong

This is a small, early-phase study (100 people) that only looks at blood pressure changes, not long-term outcomes. Results may not apply to all patients or surgeries.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.